+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hyoscine Market by Brand Type (Branded, Generic), Application (Gastrointestinal Disorders, Motion Sickness), End User, Dosage Form, Distribution Channel - Global Forecast 2025-2030- Product Image
Hyoscine Market by Brand Type (Branded, Generic), Application (Gastrointestinal Disorders, Motion Sickness), End User, Dosage Form, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Hyoscine Market by Brand Type (Branded, Generic), Application (Gastrointestinal Disorders, Motion Sickness), End User, Dosage Form, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674584
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hyoscine market is evolving rapidly in response to changing clinical needs, regulatory reforms, and technological advances that are shaping the competitive landscape for manufacturers, distributors, and healthcare providers worldwide.

Market Snapshot: Hyoscine Market Size and Growth Trajectory

The Hyoscine Market grew from USD 460.41 million in 2024 to USD 482.18 million in 2025. It is expected to continue growing at a CAGR of 4.64%, reaching USD 604.56 million by 2030.

Scope & Segmentation

  • Brand Types: Branded, Generic
  • Applications: Gastrointestinal Disorders, Motion Sickness
  • End Users: Clinics, Home Care, Hospitals
  • Dosage Forms: Injectable Solution, Oral Tablets, Transdermal Patch
  • Distribution Channels: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Regions: Americas, Europe Middle East & Africa, Asia-Pacific
  • Key Countries: United States, Canada, Mexico, Brazil, Argentina, United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland, China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Notable Manufacturers: Novartis AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Pfizer Inc.

Key Takeaways for Decision-Makers

  • Technological innovation is accelerating new hyoscine delivery formats, such as transdermal patches, alongside ongoing refinements to oral and injectable forms.
  • Regulatory flexibility, including streamlined pathways for generic approvals, is encouraging both cost-efficient production and the introduction of advanced formulations.
  • Heightened demand for antiemetics and antispasmodics is driven by demographic and lifestyle shifts, resulting in expanded requirements across both institutional and home settings.
  • Strategic alliances between pharmaceutical companies, contract manufacturers, and biotech specialists are fostering cross-disciplinary product development and broader market access.
  • Regional healthcare differences require companies to tailor go-to-market models and product portfolios for varying reimbursement practices and patient needs.

Tariff Impact on the Hyoscine Supply Chain

Newly implemented United States tariffs in 2025 have prompted significant shifts in hyoscine raw material sourcing. Pharmaceutical manufacturers are responding by forming regional supplier partnerships, developing in-house synthesis capabilities, and investing in process optimization. Collaboration between industry and regulatory authorities is expediting domestic production approval and strengthening supply continuity.

Primary Keyword: Hyoscine Market Methodology & Data Sources

The hyoscine market report’s insights are based on a blend of primary interviews with clinical and supply chain experts, procurement and patient surveys, and systematic secondary research from peer-reviewed literature, regulatory databases, and patent analytics. Triangulation was used to corroborate insights, while an advisory board of pharmacoeconomists and industry veterans provided final validation.

Why This Report Matters

  • Senior leaders can harness this research to inform investment decisions and align commercial strategies with emerging therapeutic and regulatory trends.
  • The analysis equips organizations to understand competitive positioning and adapt to changes in global sourcing, innovation, and regional healthcare dynamics.
  • Actionable recommendations assist in risk management and long-term planning for leaders operating in a shifting pharmaceutical environment.

Conclusion

The hyoscine market is entering a phase of strategic realignment, catalyzed by evolving technology, policy, and patient needs. Stakeholders who anticipate and respond to these shifts will secure growth potential and enhance competitive differentiation in anticholinergic therapy.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of generic hyoscine butylbromide formulations in emerging markets to meet cost-sensitive consumer demand
5.2. Increasing clinical trials evaluating long-acting hyoscine formulations for irritable bowel syndrome management
5.3. Integration of hyoscine hydrobromide delivery systems with patient smart monitoring technologies to improve adherence
5.4. Growing off-label use of hyoscine for motion sickness prevention in adventure tourism and cruise industries
5.5. Strategic partnerships between pharmaceutical giants and biotech firms to develop transdermal hyoscine patches with enhanced bioavailability
5.6. Regulatory approvals accelerating for novel hyoscine combination therapies targeting functional gastrointestinal disorders
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hyoscine Market, by Brand Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Hyoscine Market, by Application
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Motion Sickness
10. Hyoscine Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Hyoscine Market, by Dosage Form
11.1. Introduction
11.2. Injectable Solution
11.3. Oral Tablets
11.4. Transdermal Patch
12. Hyoscine Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.2.1. Government Hospital Pharmacy
12.2.2. Private Hospital Pharmacy
12.3. Online Pharmacy
12.3.1. Mobile App
12.3.2. Web Only Portal
12.4. Retail Pharmacy
12.4.1. Chain Pharmacy
12.4.2. Independent Pharmacy
13. Americas Hyoscine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hyoscine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hyoscine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Novartis AG
16.3.2. Teva Pharmaceutical Industries Ltd.
16.3.3. Viatris Inc.
16.3.4. Dr. Reddy’s Laboratories Ltd.
16.3.5. Sun Pharmaceutical Industries Ltd.
16.3.6. Hikma Pharmaceuticals PLC
16.3.7. Sandoz International GmbH
16.3.8. Glenmark Pharmaceuticals Ltd.
16.3.9. Wockhardt Ltd.
16.3.10. Pfizer Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HYOSCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HYOSCINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HYOSCINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HYOSCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HYOSCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HYOSCINE MARKET: RESEARCHAI
FIGURE 26. HYOSCINE MARKET: RESEARCHSTATISTICS
FIGURE 27. HYOSCINE MARKET: RESEARCHCONTACTS
FIGURE 28. HYOSCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HYOSCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HYOSCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HYOSCINE MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HYOSCINE MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HYOSCINE MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HYOSCINE MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HYOSCINE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HYOSCINE MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HYOSCINE MARKET SIZE, BY MOTION SICKNESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HYOSCINE MARKET SIZE, BY MOTION SICKNESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HYOSCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HYOSCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HYOSCINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HYOSCINE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HYOSCINE MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HYOSCINE MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HYOSCINE MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HYOSCINE MARKET SIZE, BY ORAL TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HYOSCINE MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HYOSCINE MARKET SIZE, BY TRANSDERMAL PATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HYOSCINE MARKET SIZE, BY GOVERNMENT HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HYOSCINE MARKET SIZE, BY GOVERNMENT HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HYOSCINE MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HYOSCINE MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HYOSCINE MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HYOSCINE MARKET SIZE, BY MOBILE APP, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HYOSCINE MARKET SIZE, BY WEB ONLY PORTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HYOSCINE MARKET SIZE, BY WEB ONLY PORTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HYOSCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HYOSCINE MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HYOSCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HYOSCINE MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 100. CANADA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 101. CANADA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. CANADA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. CANADA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. CANADA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. CANADA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. CANADA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. CANADA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. CANADA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. CANADA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. CANADA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 114. CANADA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 115. MEXICO HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. MEXICO HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 122. MEXICO HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 123. MEXICO HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. MEXICO HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. MEXICO HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 197. GERMANY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. GERMANY HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. GERMANY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 204. GERMANY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 205. GERMANY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. GERMANY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. GERMANY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. GERMANY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. GERMANY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. FRANCE HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. FRANCE HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. FRANCE HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 220. FRANCE HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 221. FRANCE HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. FRANCE HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. FRANCE HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. FRANCE HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. FRANCE HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 228. FRANCE HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 245. ITALY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 246. ITALY HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 247. ITALY HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. ITALY HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. ITALY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 252. ITALY HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 253. ITALY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ITALY HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. ITALY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. ITALY HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. ITALY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. ITALY HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. ITALY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 260. ITALY HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 261. SPAIN HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 262. SPAIN HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 263. SPAIN HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SPAIN HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SPAIN HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 268. SPAIN HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 269. SPAIN HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SPAIN HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. SPAIN HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. SPAIN HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. SPAIN HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. SPAIN HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. SPAIN HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 325. DENMARK HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 326. DENMARK HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 327. DENMARK HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. DENMARK HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. DENMARK HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. DENMARK HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. DENMARK HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 332. DENMARK HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 333. DENMARK HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. DENMARK HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. DENMARK HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 336. DENMARK HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 337. DENMARK HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 338. DENMARK HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 339. DENMARK HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 340. DENMARK HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 353. NETHERLANDS HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 354. NETHERLANDS HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 355. NETHERLANDS HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 356. NETHERLANDS HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 357. QATAR HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 358. QATAR HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 359. QATAR HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 360. QATAR HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 361. QATAR HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 362. QATAR HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 363. QATAR HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 364. QATAR HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 365. QATAR HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. QATAR HYOSCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. QATAR HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 368. QATAR HYOSCINE MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 369. QATAR HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 370. QATAR HYOSCINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 371. QATAR HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 372. QATAR HYOSCINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 373. FINLAND HYOSCINE MARKET SIZE, BY BRAND TYPE, 2018-2024 (USD MILLION)
TABLE 374. FINLAND HYOSCINE MARKET SIZE, BY BRAND TYPE, 2025-2030 (USD MILLION)
TABLE 375. FINLAND HYOSCINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 376. FINLAND HYOSCINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 377. FINLAND HYOSCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 378. FINLAND HYOSCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 379. FINLAND HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 380. FINLAND HYOSCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 381. FINLAND HYOSCINE MARKET SIZE, BY DISTRIBUTIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hyoscine market report include:
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals PLC
  • Sandoz International GmbH
  • Glenmark Pharmaceuticals Ltd.
  • Wockhardt Ltd.
  • Pfizer Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 482.18 Million
Forecasted Market Value ( USD ) by 2030 $ 604.56 Million
Compound Annual Growth Rate4.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Hyoscine - Global Strategic Business Report - Product Image

Hyoscine - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Hyoscine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hyoscine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Antispasmodics Drugs Market Report 2025 - Product Image

Antispasmodics Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Rivastigmine Tartrate Drug Market by Formulation (Oral Capsule, Oral Solution, Transdermal Patch), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End User, Dosage Strength, Patient Age Group, Gender - Global Forecast 2025-2030 - Product Image

Rivastigmine Tartrate Drug Market by Formulation (Oral Capsule, Oral Solution, Transdermal Patch), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End User, Dosage Strength, Patient Age Group, Gender - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Memantine & Donepezil Hydrochlorides Compound Preparation Market by Product Type (Combination, Donepezil Hydrochloride, Memantine Hydrochloride), Form (Capsule, Injectable Solution, Oral Solution), Route, Distribution Channel, End User, Dosage Type - Global Forecast 2025-2030 - Product Image

Memantine & Donepezil Hydrochlorides Compound Preparation Market by Product Type (Combination, Donepezil Hydrochloride, Memantine Hydrochloride), Form (Capsule, Injectable Solution, Oral Solution), Route, Distribution Channel, End User, Dosage Type - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From

About the Scopolamine Market

Scopolamine is a drug used to treat a variety of conditions related to the central nervous system. It is a muscarinic antagonist, meaning it blocks the action of the neurotransmitter acetylcholine. It is used to treat motion sickness, nausea, and vomiting, as well as to reduce the symptoms of Parkinson's disease. It is also used to treat irritable bowel syndrome and to reduce the symptoms of opioid withdrawal. Scopolamine is available in both oral and transdermal forms. Scopolamine is a widely used drug in the central nervous system drug market. It is used to treat a variety of conditions, and its availability in both oral and transdermal forms makes it a popular choice for many patients. It is also relatively inexpensive, making it an attractive option for those with limited budgets. Some companies in the scopolamine market include Novartis, Merck, Pfizer, and Mylan. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.